Drugs / Letrazuril
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001018 | — | HIV infectious disease, cryptosporidiosis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Letrazuril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001018 ↗ |
| Known as | Letrazurilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104819 ↗ |
| Modality | Small molecule | — CHEMBL2104819 ↗ |
| Route | Oral | “receive escalating doses of oral letrazuril (or placebo)” NCT00001018 ↗ |